| Samsung Bioepis CH GmbH - Imraldi 40 mg/0.4 ml, Injektionslösung im Fertigpen |
| 67582 | | 02 | | Imraldi 40 mg/0.4 ml | | Injektionslösung im Fertigpen | | L04AB04 | | Adalimumab | | 18.12.2024 | | |
|
| Composition |
| adalimumabum 40 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, acidum succinicum, dinatrii succinas, histidinum, histidini hydrochloridum monohydricum, mannitolum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.4 ml corresp. natrium 0.08 mg. |
| Packungsbestandteile |
| Injektionslösung im Fertigpen | | | | | | | | Principe actif | Concentr. |
|---|
| Adalimumab | 40mg / 0.4ml |
| | BAG: Principe actif | Concentr. |
|---|
| Adalimumab | 40 mg |
| | | | Agents auxilliaires |
|---|
| Acide Succinique | | Disodium Phosphate Heptahydrate | | Dinatrii Succinas | | Histidin Hydrochloride Monohydrate | | Histidine | | Mannitol | | Sodium Dihydrogenophosphate Monohydrate | | Polysorbatum 20 |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 004 | | 371.10 | 419.95 | B | LS | Non | | 005 | 2 | 742.20 | 823.50 | B | LS | Non | | 006 | 6 | 2080.98 | 2281.00 | B | LS | Non |
|
